Lord, Abbett & Co. LLC Liva Nova PLC Transaction History

Lord, Abbett & Co. LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$41.91 - $57.81 $9.5 Million - $13.1 Million	-226,711 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$39.87 - $56.9 $2.18 Million - $3.11 Million	-54,592 Reduced 19.41%	226,711 $10.9 Million
Q1 2020 May 14, 2020	SELL	$34.22 - $76.49 $4.07 Million - $9.1 Million	-118,997 Reduced 29.73%	281,303 $12.7 Million
Q4 2019 Feb 14, 2020	SELL	$68.92 - $85.27 $7.6 Million - $9.4 Million	-110,217 Reduced 21.59%	400,300 $30.2 Million
Q3 2019 Nov 14, 2019	BUY	$71.74 - $86.35 $13.3 Million - $16 Million	184,776 Added 56.72%	510,517 $37.7 Million
Q2 2019 Aug 14, 2019	SELL	$66.45 - $97.36 $8.59 Million - $12.6 Million	-129,241 Reduced 28.41%	325,741 $23.4 Million
Q1 2019 May 15, 2019	SELL	$86.15 - $100.49 $1.94 Million - $2.26 Million	-22,510 Reduced 4.71%	454,982 $44.2 Million
Q4 2018 Feb 14, 2019	SELL	$84.14 - $125.42 $3.38 Million - $5.04 Million	-40,209 Reduced 7.77%	477,492 $43.7 Million
Q3 2018 Nov 14, 2018	BUY	$101.02 - $130.95 $23.6 Million - $30.6 Million	233,328 Added 82.05%	517,701 $64.2 Million
Q2 2018 Aug 14, 2018	BUY	$81.75 - $105.37 $23.2 Million - $30 Million	284,373 New	284,373 $28.4 Million

262

52.9M

316K

127K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.5B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.